NCT00133705View on ClinicalTrials.gov

Trial of Mifepristone for Fibroids

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Leiomyoma
Interventions
DRUG

Mifepristone

Mifepristone 5mg/day by mouth for 6 months

DRUG

Inert Capsule

sugar pill

Trial Locations (1)

14642

University of Rochester School of Medicine & Dentistry, Rochester

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Rochester

OTHER

NCT00133705 - Trial of Mifepristone for Fibroids | Biotech Hunter | Biotech Hunter